Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.64 USD | +4.22% |
|
+19.06% | +230.27% |
Jul. 01 | Summit Therapeutics Inc.(NasdaqGM:SMMT) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Summit Therapeutics Inc.(NasdaqGM:SMMT) dropped from Russell Microcap Growth Index | CI |
Business Summary
Number of employees: 105
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 | |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Dave Gancarz
IRC | Investor Relations Contact | - | 20-10-31 |
Bhaskar Anand
AUD | Comptroller/Controller/Auditor | 46 | - |
Campbell Hair
HRO | Human Resources Officer | - | 20-09-30 |
Betty Chang
PRN | Corporate Officer/Principal | - | 21-05-31 |
Urte Gayko
LAW | General Counsel | 53 | 21-11-02 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Mostafa Ronaghi
BRD | Director/Board Member | 55 | Apr. 10 |
Kenneth Clark
BRD | Director/Board Member | 65 | 21-10-06 |
Director/Board Member | 63 | 22-11-14 | |
Urte Gayko
LAW | General Counsel | 53 | 21-11-02 |
Michelle Xia
BRD | Director/Board Member | 57 | 23-01-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 701,979,596 | 83,228,173 ( 11.86 %) | 0 | 11.86 % |
Company contact information
![address Summit Therapeutics Inc.(SMMT)](https://cdn.zonebourse.com/static/address/21452860.png)
Sector
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+230.27% | 5.82B | |
+21.06% | 127B | |
+23.47% | 116B | |
+25.15% | 27.69B | |
-19.39% | 19.62B | |
-16.57% | 16.26B | |
-16.34% | 15.49B | |
+11.62% | 14.81B | |
-46.65% | 14.39B | |
+56.62% | 14.11B |
- Stock Market
- Equities
- SMMT Stock
- Company Summit Therapeutics Inc.